Drug intelligence / Profile preview

Zhulong Huoxuetongyu granules

Development stage
Phase 1
Lead developer
Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Zhulong Huoxuetongyu granules (also referred to as Zhilong Huoxuetongyu granules) is a Traditional Chinese Medicine (TCM) hospital preparation developed by the Hospital of Traditional Chinese Medicine affiliated to Southwest Medical University. It is specifically formulated for the treatment of acute ischemic stroke characterized by the TCM syndrome of Qi deficiency and blood stasis. The formulation is designed to invigorate blood circulation and resolve blood stasis (Huoxue Tongyu), utilizing active components from ingredients such as Leech (Shuizhi) and Earthworm (Dilong). The drug is currently being evaluated in Phase 1 clinical trials in China to assess its efficacy and safety as an adjunctive therapy to standard basic treatment for patients with cerebral infarction.

Other names
Zhilong Huoxuetongyu granulesZhilong Huoxue Tongyu granulesZhulong Huoxuetongyu keli猪龙活血通瘀颗粒蛭龙活血通瘀颗粒
02

Targets

Fibrin (Factor Ia)F2 (Thrombin)

Beyond the preview

Go deeper on Zhulong Huoxuetongyu granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zhulong Huoxuetongyu granules.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call